Trial Outcomes & Findings for Effect of Lidocaine and Esmolol to Improve the Quality of Recovery (NCT NCT01114997)

NCT ID: NCT01114997

Last Updated: 2016-11-03

Results Overview

Outcome had a duration of one day at post-anesthesia care unit (PACU) Postoperative pain measured using a Verbal Rating Scale (VRS) Postoperative pain VRS scores: 0 = none pain to 10 = intolerable pain.

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

32 participants

Primary outcome timeframe

1 day

Results posted on

2016-11-03

Participant Flow

Participant milestones

Participant milestones
Measure
Lidocaine
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction:Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Overall Study
STARTED
11
10
11
Overall Study
COMPLETED
11
10
11
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Lidocaine and Esmolol to Improve the Quality of Recovery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-Induction (Maintenance Infusion): Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Total
n=32 Participants
Total of all reporting groups
Age, Continuous
42 years
STANDARD_DEVIATION 8 • n=5 Participants
44 years
STANDARD_DEVIATION 3 • n=7 Participants
38 years
STANDARD_DEVIATION 10 • n=5 Participants
41 years
STANDARD_DEVIATION 9 • n=4 Participants
Sex: Female, Male
Female
11 Participants
n=5 Participants
10 Participants
n=7 Participants
11 Participants
n=5 Participants
32 Participants
n=4 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Region of Enrollment
United States
11 participants
n=5 Participants
10 participants
n=7 Participants
11 participants
n=5 Participants
32 participants
n=4 Participants

PRIMARY outcome

Timeframe: 1 day

Outcome had a duration of one day at post-anesthesia care unit (PACU) Postoperative pain measured using a Verbal Rating Scale (VRS) Postoperative pain VRS scores: 0 = none pain to 10 = intolerable pain.

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Post Operative Pain
4 Score on a scale
Standard Deviation 4
2 Score on a scale
Standard Deviation 2
4 Score on a scale
Standard Deviation 3

PRIMARY outcome

Timeframe: 1 month

Population: Experience of pain at home

Highest Post Operative pain one month after surgery, using a verbal rating score from 0 (no pain) to 10 (highest level of pain). Patient received a post-operative follow-up call one month after surgery.

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Number of Participants With Post Operative Pain One Month After Surgery
10 participants
8 participants
10 participants

SECONDARY outcome

Timeframe: 1 day

Population: Opioid: Hydromorphone

Postoperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts)

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Opioid Consumption Obtained From the Recorded Data
1.5 mg
Standard Deviation 1
1 mg
Standard Deviation 0.8
1.5 mg
Standard Deviation 1

SECONDARY outcome

Timeframe: 1day

Postoperative nausea using a Verbal Rating Scale Outcomes measured at the first day after surgery

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Number of Participants With Postoperative Nausea One Day After Surgery
3 participants
2 participants
3 participants

SECONDARY outcome

Timeframe: 1 month

Description: return to normal activities of daily living(including dietary intake, bowel and bladder function, physical activities)

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Return to Normal Activities of Daily Living Using Follow up Questionnaires
10 participants
8 participants
8 participants

SECONDARY outcome

Timeframe: 1 month

Patient satisfaction using a verbal rating scale from 0 to 10 0= Not satisfied 10= Excellent

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Patient Satisfaction
9.4 Score on a scale
Standard Deviation 0.8
9.2 Score on a scale
Standard Deviation 1
8.3 Score on a scale
Standard Deviation 2

SECONDARY outcome

Timeframe: 1 day

Outcome measures

Outcome measures
Measure
Lidocaine
n=11 Participants
Pre-Induction: Lidocaine Loading: 1 mg/kg Post- Induction: Lidocaine Infusion: 12.5-25 mcg/kg/min 0.75-1.5 mg/kg/h)
Esmolol
n=10 Participants
Pre-Induction: Esmolol Loading dose: 750 mcg/Kg (0.75 mg/kg) Post-Induction: Infusion dose 7.5 - 15 mcg /kg/min
Lidocaine + Esmolol (Combo)
n=11 Participants
Pre-induction: Lidocaine Loading dose(1 mg/kg)+Esmolol Loading dose(750 mcg/Kg) Post-induction: Infusion rate: Lidocaine(12.5-25 mcg/kg/min) + Esmolol(7.5-15 mcg/kg/min)
Post-anesthesia Care Unit (PACU) Stay
236 Minutes
Standard Deviation 147
116 Minutes
Standard Deviation 38
214 Minutes
Standard Deviation 125

Adverse Events

Lidocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Esmolol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Lidocaine + Esmolol (Combo)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Roya Yumul

Cedars Sinai Medical Center

Phone: 310-423-1682

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place